Changes of pharmacokinetics of Trimethoprim after pretreatment with streptococcal Peptidoglycan

  • J. Lavický
  • J. Černý
  • L. Čeleda
  • J. Rotta
  • J. Květina
  • H. RaŠková
  • A. Kubíček


Trimethoprim (TMP) 10−1 was given orally to calves and rabbits. Two to three weeks later the animals were pretreated by i.v. Peptidoglycan (Pt) 20 μ−1. One hour later TMP was administered as above. To other animals under otherwise identical conditions TMP was injected intravenously. The pretreatment with Peptidoglycan induced in both species a significant increase of TMP serum levels positively correlated with temperature elevation. Peptidoglycan pretreatment increased the bioavailability of TMP.


Trimethoprim Peptidoglycan pharmacokinetics calves rabbits 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lapka R., Urbanová Z., Kobylka B., Rašková H., Vaněček J. and Polák L. (1978): Pharmacokinetics of sulfadimidine in normal and diarrheic calves. Drug Metab. Disp.,6, 637–639.Google Scholar
  2. 2.
    Sechserová M., Sechser T., Rašková H., Elis J., Vaněček J., Polák L., Matějovská D. and Raška K. (1979): Ontogenic Drug Studies in Calves. II. Changes in salicylate levels and metabolism in calves with diarrhoea. Arzneim.-Forsch.,29, 5, 804–807.Google Scholar
  3. 3.
    Rašková H., Lapka R., Langmeierová M., Urbanová Z., Černý J., Vaněček J., Kubiček A. and Polák L. (1980): Escherichia coli endotoxin and enterotoxin implication on pharmacokinetics of drugs, Natural Toxins pp. 369–376, Ed. D. Eaker and T. Wadström, Pergamon Press Oxford and New York.Google Scholar
  4. 4.
    Rašková H. and Mašek K. (1971): Streptococcal Toxins. In: Microbial Toxins, International Encyclopedia Pharmacology and Therapeutics, Sect. 7, Vol. 1, p. 39 (Rašková ed.), Oxford.Google Scholar
  5. 5.
    Rotta J. and Scheifer K.H. (1974): Pyrogenic activity of bacterial mucopeptides. J. Hyg. Microbiol., Immunol.,18, 50–59.Google Scholar
  6. 6.
    Heymer B. (1975): Biological Properties of the Peptidoglycan. Z. Immun. Forsch.,149, 245–257.Google Scholar
  7. 7.
    Krause M.R. and McCarty J.J. (1961): Studies on the chemical structure of the streptococcal cell walls. I. The identification of mucopeptide in the cell walls of groups A and A-variant streptococci. J. Exp. Med.,114, 127.CrossRefPubMedGoogle Scholar
  8. 8.
    Schwartz D.E., Koechlin B.A. and Weinfeld R.E. (1969): Spectrofluorometric method for the determination of Trimethoprim in body fluids. Chemotherapy,14, 22–29.CrossRefPubMedGoogle Scholar
  9. 9.
    Van Miert A.S.J.P.A.M., Van Gogh H. and Wit J.G. (1976): The influence of pyrogen induced fever on absorption of sulfa drugs. Vet. Ree,99, 480–481.Google Scholar
  10. 10.
    Ladefoged O. (1977): Pharmacokinetics of Trimethoprim in normal and febrile rabbits. Acta Pharmacol. Toxicol.,41, 507–514.CrossRefGoogle Scholar
  11. 11.
    Lapka R., Langmeierová M., Vaněček J. and Rašková H. (1980): Changes of pharmacokinetics and metabolism of sulfadimidine in endotoxin pretreated rabbits. Arch. Toxicol. Suppl.,4, 325–327.PubMedGoogle Scholar
  12. 12.
    Lavický J., Čeleda L., Urbanová Z., Rašková H., Květina J., Vaněček J., Hofman J. and Kubiček A. (1984): Vliv endo-toxinu na hladiny rifampicinu v séru telat. Čas. lék. čes., 123,22, 681–682 (In Czech).Google Scholar
  13. 13.
    Mašek K., Rašková H. and Rotta J. (1968): The mechanism of the pyrogenic effect of streptococcus cell wall mucopeptide. J. Physiol.,192, 345–349.Google Scholar
  14. 14.
    Mašek K., Rašková H. and Rotta J. (1972): On the mechanism of fever caused by the mucopeptide of group A streptococcus. Naunyn-Schmiedebergs Arch. Pharmakol.,274, 138–145.CrossRefGoogle Scholar
  15. 15.
    Van Miert A.S.J.P.A.M., De la Parra D.A. (1970): Inhibition of gastric emptying by endotoxin in conscious rats and modification of this response by drugs affecting the autonomic nervous system. Arch. Int. Pharmacodyn. Ther.,184, 27–33.PubMedGoogle Scholar
  16. 16.
    Lefebvre R., Čeleda L., Morávek J. Hofman J. and Rašková H. (1983): Influence of endotoxin on the pharmacokinetics of rifampicin in rabbits. Physiol. Bohemosl.,32, 381–384.Google Scholar
  17. 17.
    Mašek K., Paegelow I., Rašková H., Pávek K. and Rotta J. (1973): Hemodynamic effects of group A streptococcus mucopeptide. Proc. Soc. Exp. Biol. Med.,144, 1020–1024.PubMedGoogle Scholar
  18. 18.
    Lapka R., Čeleda L., Černý J., Sýkora Z., Urbanová Z, Rašková H., Vaněček J. and Kubiček A. (1980): Ontogenic changes of trimethoprim/sulfadiazine pharmacokinetics. Zbk, Pharm.,119, 1056–1059.Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • J. Lavický
    • 1
  • J. Černý
    • 2
  • L. Čeleda
    • 2
  • J. Rotta
    • 3
  • J. Květina
    • 1
  • H. RaŠková
    • 4
  • A. Kubíček
    • 4
  1. 1.Department of Pharmacology, Pharmaceutical FacultyCharles UniversityHradec Králové
  2. 2.Institute of Postgraduate Veterinary MedicineDukovany
  3. 3.Institute of Hygiene and EpidemiologyPrague
  4. 4.Czechoslovak Academy of SciencesPragueCzechoslovakia

Personalised recommendations